medigraphic.com
ISSN 1561-3011 (Electronic)

2011, Number 4

<< Back Next >>

Rev Cubana Invest Bioméd 2011; 30 (4)

Prevalence of the metabolic syndrome in dyslipidemia patients with a history of myocardial revascularization

Cabalé VMB, Sánchez SD, Gutiérrez CE, Flores SA

Language: Spanish
References: 17
Page: 464-470
PDF size: 141.17 Kb.


ABSTRACT

Introduction: The metabolic syndrome is characterized by the convergence of some risk factors in the same subject which has been the object of interest in past years due to its high prevalence in healthy populations and in those with a history of cardiovascular affections.
Objective: To determine the prevalence of metabolic syndrome in dyslipidemia patients with myocardial revascularization.
Methods: A descriptive study was conducted including 100 dyslipidemia patients and with revascularization. Authors used the diagnostic criterion established by WHO for the classification of patients.
Results: The 43 % of population had metabolic syndrome whose presence was in an inverse relation to age. The prevalence of its components was greater in male sex.
Conclusions: The obtained prevalence of the MS is high coinciding with international studies on secondary prevention.


REFERENCES

  1. Pineda CA. Síndrome metabólico: definición, historia, criterios. Colomb Med. 2008;39(1):96-106.

  2. Madrid-Miller A, Alcaraz-Ruiz A, Borrayo-Sánchez G, Almeida-Gutiérrez E, Vargas-Guzmán RM, Jáuregui-Aguilar R. Síndrome metabólico, impacto clínico y angiográfico en pacientes con síndrome coronario agudo. Cir Cir. 2010;78:115-123.

  3. Mente A, Yusuf S, Islam S, McQueen M, Tanomsup S, Onen Ch, et al. Metabolic syndrome and risk of acute myocardial infarction. A case-control study of 26 903 subjects from 52 countries. J Am Coll Cardiol. 2010;55:2390-98.

  4. Cabalé Vilariño MB, Flores Sánchez A, Sánchez Serrano D. Prevalencia del síndrome metabólico en dislipidémicos. Rev Cubana Med. 2006;45(3).

  5. Kim JS, Lee HC, Choi BK, Lee HW, Park JS, Lee YH, et al. Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation. Diabetes Research and Clinical Practice. 2010;88:38-41.

  6. Mozaffarian D, Kamineni A, Prineas RJ, Siscovick DS. Metabolic syndrome and mortality in older adults: The Cardiovascular Health Study. Arch Intern Med. 2008;168(9):969-78.

  7. Ninomiya JK, L'Ítalien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109:42-6.

  8. Hu R, Ma CS, Nie SP, La Q, Kang JP, Du X, et al. Metabolic syndrome may be better at predicting the prognosis of coronary artery disease than other traditional cardiovascular risk factors. Zhonghua Yi Xue Za Zhi. 2010;90(22):1537-41.

  9. Brunner EJ, Marmot MG, Nanchahal K, Stanfeld SA, Juneja M, Alberti KG. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II Study. Diabetologia. 1997;40:1341-9.

  10. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian Adults: a population study using modified ATP criteria. Diabetes Res Clin Pract. 2003;60:199-204.

  11. Hernández A, Riera C, Solá E, Oliver MJ, Martínez ML, Morillas C, et al. Prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica. Med Clin. 2003;121:204-8.

  12. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyles change with cardiac rehabilitation. Am J Cardiol. 2003;92:50-4.

  13. Alberti KG, Zimmet PZ, for the WHO Consultation, Definition, Diagnosis and Classification of Diabetes mellitus, personal report of WHO consultation. Diabetes Med. 1998;15:539-53.

  14. Yasein N, Ahmad M, Matrook F, Nasir L, Froelicher ES. Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan. EMHJ. 2010;16(4):375-380.

  15. Olijhoeka JK, Van der Graafb Y, Bangaa JD, Ale Algrab A, Rabelinka TJ, Visserena FL. The metabolic syndrome is associated with advanced damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25:342-8.

  16. Serruys PW, Morice MC, Colombo A, The SYNTAX investigators. Angioplastia vs. cirugía de revascularización miocárdica en la enfermedad coronaria severa. NEJM. 2009;360:961-72.

  17. Thomas F, Pannier B, Benetos A, Vischer UM. The impact of the metabolic syndrome-but not of hypertension-on all-cause mortality disappears in the elderly. J Hypertens. 2010;29(4):663-8.




2020     |     www.medigraphic.com